Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Poseida Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 86 | 2 | 91 | +7 |
| Shares | 45.2M | 12.4K | 45.3M | +145.4K (+0.3%) |
| Value | $107.6M | $30.0K | $152.4M | +$44.8M (+41.6%) |
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Poseida Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 438,326 | $1.47M | 0.01% |
| Marex Group plc | 118,161 | $397.0K | 0.02% |
| Cantor Fitzgerald, L. P. | 50,205 | $168.7K | 0.04% |
| Ameriprise Financial Inc | 37,514 | $126.0K | 0.00% |
| Jane Street Group, LLC | 29,483 | $99.1K | 0.00% |
| Public Employees Retirement System of Ohio | 22,700 | $76.3K | 0.00% |
| Engineers Gate Manager LP | 19,601 | $65.9K | 0.00% |
| State Board of Administration of Florida Retirement System | 17,651 | $59.3K | 0.00% |
| Rothschild Investment LLC | 12,000 | $40.3K | 0.00% |
| Dynamic Technology Lab Private Ltd | 10,459 | $36.0K | 0.00% |
| Simplex Trading, LLC | 6,588 | $22.0K | 0.00% |
| Point72 Middle East FZE | 5,341 | $17.9K | 0.00% |
| Group One Trading, L.P. | 4,717 | $15.8K | 0.00% |
| National Bank of Canada | 1,500 | $5.07K | 0.00% |
| Voisard Asset Management Group, Inc. | 270 | $908 | 0.00% |
| Farther Finance Advisors, LLC | 102 | $343 | 0.00% |
| Nisa Investment Advisors, LLC | 41 | $138 | 0.00% |
Sold out (10)
Institutions that held Poseida Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Squarepoint Ops LLC | 222,315 | $529.1K |
| Deutsche Bank AG | 35,880 | $85.4K |
| Penserra Capital Management LLC | 35,496 | $84.0K |
| Allspring Global Investments Holdings, LLC | 12,247 | $29.1K |
| Winton Group Ltd | 10,577 | $25.2K |
| Two Sigma Securities, LLC | 10,105 | $24.1K |
| Principal Financial Group Inc | 10,000 | $23.8K |
| China Universal Asset Management Co., Ltd. | 2,225 | $5.30K |
| Citadel Advisors LLC | 746 | $1.77K |
| Daiwa Securities Group Inc. | 346 | $1.00K |
Not filed for Q4 2023 yet (2)
Institutions that held Poseida Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Rothschild Investment Corp | 12,000 | $29.0K |
| Antonetti Capital Management LLC | 400 | $952 |